Takara Bio, Konica Minolta to Co-develop Compact Chlamydia Testing System
Main Category: Sexual Health / STDsArticle Date: 24 Jan 2005 - 12:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  | |
| Healthcare Prof: | |
Tokyo (JCNN) - Takara Bio (TSE: 4974) and Konica Minolta (TSE: 4902) have jointly announced that they have agreed to co-develop an inspection system targeting chlamydia.
The system combines Takara Bio's proprietary isothermal DNA amplification method ICAN (Isothermal and Chimeric primer-initiated Amplification of Nucleic acids) and Konica Minolta's Micro Total Analysis Systems muTAS and micropump technology, and accurately and simply detects the chlamydia virus.
The system consists of three components: a sample preprocessing device, disposable microchip, and compact desktop analyzer.
The two companies plan to develop the system within a year and commercialize it in 2008.
View Konica Minolta Holdings,Inc. company profile here
View Takara Bio Inc. company profile here
Copyright © 2001-2004 JCNN. All rights reserved. A division of Japan Corporate News Network KK.
Visit our sexual health / stds section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/19193.php>
APA
http://www.medicalnewstoday.com/releases/19193.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
